IMS — Invent Medic Sweden AB Cashflow Statement
0.000.00%
- SEK19.46m
- SEK17.79m
- SEK7.35m
Annual cashflow statement for Invent Medic Sweden AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.4 | -18.8 | -11.8 | -8.15 | -6.22 |
| Depreciation | |||||
| Changes in Working Capital | -1.42 | 0.401 | -1.84 | 0.49 | -1.61 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -16.2 | -17.8 | -13 | -6.74 | -7.52 |
| Capital Expenditures | -0.644 | -0.937 | -0.156 | -0.256 | -0.186 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | -4.21 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.644 | -0.937 | -0.156 | -4.46 | -0.186 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 25.2 | 23.7 | 0.383 | 9.7 | 7.41 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.29 | 4.9 | -12.7 | -1.51 | -0.3 |